Neuronetics STIM Product — Cost of Goods Sold
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Neuronetics in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuronetics's product — cost of goods sold.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Neuronetics's product — cost of goods sold?
- Neuronetics (STIM) reported product — cost of goods sold of $2.86M in Q1 2026.
- How has Neuronetics's product — cost of goods sold changed year-over-year?
- Neuronetics's product — cost of goods sold decreased by 9.3% year-over-year, from $3.15M to $2.86M.
- What does product — cost of goods sold mean?
- This metric captures the direct costs associated with the manufacturing, assembly, and delivery of the company's medical technology products. It includes expenses such as raw materials, direct labor, and overhead costs directly attributable to the production of the therapeutic systems. Monitoring this cost provides insight into the company's manufacturing efficiency and the direct margin profile of its product segment.